Please login to the form below

Not currently logged in
Email:
Password:

Kleemann joins Merck from Boehringer

Appointed head of group tax

Pharma finance veteran Sylvia Kleemann is to leave Boehringer Ingelheim to join rival German pharma firm Merck KGaA as head of group tax at the beginning of 2014.

Kleeman served as head of corporate tax at Boehringer and has additional life sciences experience at KPMG, Celanese and Fresenius Medical Care.

In her new role, she will report to chief financial officer Matthias Zachert. She replaces Armin Gembruch who has been head of group tax since May 2011.

Zachert said: “Sylvia Kleemann has extensive experience in both the pharmaceutical and the chemical industries. At the same time, Sylvia Kleemann has a very broad understanding of both public and family-owned companies, which makes her ideally suited for her new position at Merck.”

3rd December 2013

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...